BRIEF published on 08/18/2026 at 21:55, 26 days 6 hours ago Piramal Pharma acquiert une participation majoritaire dans Yapan Bio Acquisition Produits Biologiques Piramal Pharma Yapan Bio Services CDMO
BRIEF published on 08/18/2026 at 21:55, 26 days 6 hours ago Piramal Pharma Secures Majority Stake in Yapan Bio Acquisition Biologics Piramal Pharma Yapan Bio CDMO Services
PRESS RELEASE published on 08/18/2026 at 21:50, 26 days 6 hours ago Piramal Pharma Limited Completes Acquisition of Controlling Stake in Yapan Bio Private Limited Piramal Pharma Ltd. completes acquisition of controlling stake in Yapan Bio Private Limited, enhancing biologics capabilities and CDMO services Acquisition CDMO Biologics Piramal Pharma Ltd. Yapan Bio Private Limited
BRIEF published on 08/04/2026 at 11:20, 1 month 9 days ago Piramal Pharma Solutions modernise son site de production de peptides avec une nouvelle unité de séchage par pulvérisation. Expansion Pharmaceutique Solutions Pharmaceutiques Piramal HPAPI Séchage Par Pulvérisation Formulation Peptidique
BRIEF published on 08/04/2026 at 11:20, 1 month 9 days ago Piramal Pharma Solutions Enhances Peptide Facility with New Spray Drying Suite Pharmaceutical Expansion Piramal Pharma Solutions Spray Drying Peptide Formulation HPAPIs
PRESS RELEASE published on 08/04/2026 at 11:15, 1 month 9 days ago Piramal Pharma Solutions Expands Peptide API Facility with Advanced Spray Drying Suite Piramal Pharma Solutions launches state-of-the-art spray drying suite at peptide facility in Turbhe, India to address formulation challenges for peptides and complex molecules Peptides Piramal Pharma Solutions Spray Drying Suite Formulation Challenges Turbhe
BRIEF published on 06/22/2026 at 11:05, 2 months 21 days ago Piramal Pharma Solutions Achieves Strong Audit Performance Digital Transformation Regulatory Approvals Customer Audits Quality Strategy Operational Effectiveness
BRIEF published on 06/22/2026 at 11:05, 2 months 21 days ago Piramal Pharma Solutions obtient d'excellents résultats en matière d'audit. Transformation Numérique Efficacité Opérationnelle Approbations Réglementaires Audits Clients Stratégie Qualité
PRESS RELEASE published on 06/22/2026 at 11:00, 2 months 21 days ago Piramal Pharma Solutions Highlights Strong Performance Across More Than 200 Customer Audits Piramal Pharma Solutions completes over 200 customer audits and 70+ regulatory approvals, showcasing commitment to quality and operational excellence Regulatory Approvals Piramal Pharma Solutions Customer Audits Quality Strategy Global CDMO
BRIEF published on 05/18/2026 at 15:10, 3 months 26 days ago Piramal Pharma Solutions Partners with Botanix for Sofdra Development FDA Approval Partnership Supply Chain Pharmaceutical Development Sofdra
Published on 09/12/2026 at 02:35, 2 days 1 hour ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 2 days 5 hours ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 21:25, 2 days 6 hours ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 2 days 11 hours ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/14/2026 at 02:05, 2 hours 5 minutes ago Shanghai Electric Secures First Overseas Heavy-Duty Gas Turbine Order for 500 MW Malaysian Project
Published on 09/13/2026 at 16:45, 11 hours 25 minutes ago Journées européennes du patrimoine : un succès populaire pour l'ouverture exceptionnelle du Siège de la Vaudoise
Published on 09/12/2026 at 17:50, 1 day 10 hours ago New Delhi Marks UN Day for South-South Cooperation with Push to Scale Dryland Innovation Across the Global South
Published on 09/12/2026 at 07:30, 1 day 20 hours ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 2 days 5 hours ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 07:00, 2 days 21 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 2 days 21 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 3 days 8 hours ago Availability of the 2026 Interim Financial Report
